IP Library Granted Patent US 10,265,537
Granted Patent B2
US 10,265,537 · App. 15/601,719 · Granted Apr 23, 2019

Aesthetic method of biological structure treatment by magnetic field

Inventor: Tomás Schwarz (Prague, CZ)
Assignee: Medical Technologies CZ a.s.
A61N2/02A61F7/007A61F7/0053A61N2/004A61F2007/0056A61F2007/0075A61F2007/029
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,265,537
App. No.
15/601,719
Granted
Apr 23, 2019
Kind
B2
Abstract

In methods for treating a patient, a time varying magnetic field is applied to a patient's body and causes a muscle contraction. The time-varying magnetic field may be monophasic, biphasic, polyphasic and/or static. The method may reduce adipose tissue, improve metabolism, blood and/or lymph circulation. The method may use combinations of treatments to enhance the visual appearance of the patient.

Claims (56)

1. A method for reducing adipose cells, cellulite, causing circumferential reduction or changing BMI of a patient using a treatment device which generates a time-varying magnetic field applied to a muscle of a patient, wherein the treatment device includes a connection to an energy source, a switching device, an energy storage device and at least a first magnetic field generating device and a second magnetic field generating device, comprising:

positioning a first applicator having the first magnetic field generating device and a second applicator having the second magnetic field generating device into contact with the patient;

providing at least one of the first applicator and the second applicator in a static position via a positioning member;

charging the energy storage device;

switching the switching device in order to enable discharging energy from the energy storage device to at least one of the first magnetic field generating device and the second magnetic field generating device, generating the time-varying magnetic field;

applying the time-varying magnetic field to the muscle of the patient in order to contract the muscle; and

cooling adipose cells to a temperature in a range of 37 to −10° C.

2. The method of claim 1 further comprising applying the time-varying magnetic field with a magnetic flux density in a range of 0.5 and up to 7 T, with a repetition rate in a range of 1 to 700 Hz, with an impulse duration in a range of 3 to 10000 μs and with a maximal value of a magnetic flux derivative in a range of 500 T/s to 150 kT/s to a peripheral neural system in at least one body region consisting of thighs, saddlebags, buttocks, abdomen, hips, love handles, torso or arms of the patient.

3. The method of claim 1 further comprising cooling at least one of the first magnetic field generating device and the second magnetic field generating device.

4. The method of claim 1 further comprising using a signal from a sensor measuring a physical quantity of a hardware component of the treatment device including one or more of voltage, current, a phase shift, a magnetic flux density or a temperature in order to adjust an output power which is applied to the patient.

5. The method of claim 1 further comprising using a signal from a sensor measuring a physical quantity of a hardware component of the treatment device including one or more of voltage, current, a phase shift or a magnetic flux density in order to determine an unintended event including a hardware error or a metal object within proximity of the treatment device.

6. The method of claim 1 wherein the positioning member is flexible.

7. A method for reducing adipose cells, cellulite, causing circumferential reduction or changing BMI of a patient using a device which generates a time-varying magnetic field applied to a muscle of patient's body, wherein the device includes a connection to an energy source, a switching device, an energy storage device and a magnetic field generating device encased in an applicator, comprising:

placing the applicator in contact with the patient on at least one body region consisting of thighs, saddlebags, buttocks, abdomen, hips, love handles, torso or arms of the patient;

using a positioning member to maintain the applicator in contact with the at least one body region;

charging the energy storage device from the energy source;

switching the switching device in order to enable discharging energy from the energy storage device to the magnetic field generating device, to generate the time-varying magnetic field;

assembling magnetic pulses to bursts wherein each burst consists of a plurality of subsequent magnetic pulses and a time period of not applying the time varying magnetic field and wherein the bursts have a treatment duty cycle of at least 10%;

applying the time-varying magnetic field with a magnetic flux density over 0.1 and up to 7 T, with a repetition rate in a range of 1 to 700 Hz, with an impulse duration in a range of 3 to 10000 μs and with a maximal value of a magnetic flux derivative in a range of 500 T/s to 150 kT/s to a peripheral neural system in the at least one body region in order to repetitively contract the muscle, reduce adipose cells or cellulite, cause circumferential reduction or change BMI of the patient.

8. The method of claim 7 wherein the positioning member includes a buckle.

9. The method of claim 7 further comprising using a signal from a sensor measuring a physical quantity of a hardware component of the treatment device including one or more of voltage, current, a phase shift or a magnetic flux density in order to determine an unintended event including a hardware error or a metal object within proximity of the device.

10. The method of claim 7 further comprising using a signal from a sensor measuring a physical quantity of a hardware component of a treatment device including one or more of voltage, current, a phase shift, a magnetic flux density or a temperature; and

evaluating the signal and providing at least one maximal treatment parameter including the magnetic flux density, the repetition rate and the impulse duration to an operator in a human perceptible form based on one or more treatment parameters set by the operator.

11. The method of claim 10 further comprising increasing blood perfusion and releasing free fatty acids from at least one adipose cell.

12. The method of claim 7 further comprising generating radiofrequency waves by the magnetic field generating device which generates the time-varying magnetic field.

13. A method for reducing adipose cells, cellulite, causing circumferential reduction or changing BMI of a patient using a device which generates a time-varying magnetic field applied to a muscle of a patient, wherein the device includes a connection to an energy source, a switching device, an energy storage device and a magnetic field generating device encased in an applicator, comprising:

placing the applicator in a contact with the patient in at least one body region consisting of at least one of thighs, saddlebags, buttocks, abdomen, hips, love handles, torso or arms of the patient, the magnetic field generating device having a conductor diameter less than 3 mm;

charging the energy storage device;

switching the switching device in order to enable a plurality of discharges from the energy storage device to the magnetic field generating device in order to generate a plurality of the time-varying magnetic field pulses with a magnetic flux density in a range of 0.5 to 7 T, with a repetition rate in a range of 1 to 700 Hz, with an impulse duration in a range of 3 to 10000 μs and with a maximal value of a magnetic flux derivative in a range of 500 T/s to 150 kT/s;

applying the time-varying magnetic field to a peripheral neural system in the at least one body region of the patient in order to cause at least one contraction of the muscle followed by resting time and repeating this step for at least 120 seconds.

14. The method of claim 13 further comprising cooling the magnetic field generating device by a fluid cooling media.

15. The method of claim 14 further comprising using a signal from a sensor measuring physical quantity of a hardware component of the treatment device including one or more of voltage, current, a phase shift or a magnetic flux density in order to determine an unintended event including a hardware error or a metal object within proximity of the device; and

ceasing generating the time-varying magnetic field in the case of determining the unintended event.

16. The method of claim 15 further comprising using a plurality of magnetic field generating devices, and using the signal from the sensor to position the plurality of magnetic field generating devices.

17. The method of claim 13 further comprising reducing visceral white adipose tissue.

18. The method of claim 13 wherein the device further includes a high-frequency generator and an electrode, and further comprising converting an unbalanced radiofrequency signal to a balanced radiofrequency signal.

19. The method of claim 18 further comprising applying radiofrequency waves of a frequency in a range of 1 MHz to 100 GHz in order to heat the adipose cells.

20. The method of claim 19 further comprising causing no thermal treatment by the magnetic field generating device.

21. The method of claim 13 further comprising generating radiofrequency waves by the magnetic field generating device which generates the time-varying magnetic field.

22. The method of claim 13 further comprising using a signal from a sensor measuring a physical quantity of a hardware component of the treatment device including one or more of voltage, current, a phase shift, a magnetic flux density or a temperature; and

evaluating the signal and providing at least one maximal treatment parameter including the magnetic flux density, the repetition rate and the impulse duration to an operator in a human perceptible form based on one or more treatment parameters set by the operator.

23. A method for reducing adipose cells, cellulite, causing circumferential reduction or changing BMI of a patient using a device which generates a time-varying magnetic field applied to a patient's body, wherein the device includes a connection to an energy source, a switching device, an energy storage device and a magnetic field generating device within an applicator, comprising:

placing the applicator in contact with the patient, the magnetic field generating device including a litz-wire;

charging the energy storage device;

switching the switching device in order to enable discharging energy from the energy storage device to the magnetic field generating device in order to generate impulses of the time-varying magnetic field having a biphasic shape with a repetition rate in a range of 1 to 700 Hz, with an impulse duration in a range of 3 to 10000 μs and with a maximal value of a magnetic flux derivative in a range of 500 T/s to 150 kT/s;

applying the time-varying magnetic field with at least motor-threshold magnetic flux density to a peripheral neural system innervating at least one muscle of the patient in order to repetitively contract the at least one muscle within at least one body region consisting of at least one of thighs, saddlebags, buttocks, abdomen, hips, love handles, torso or arms of the patient and repeating this step for at least 120 seconds; and

cooling the magnetic field generating device by a fluid cooling media.

24. The method of claim 23 wherein the device further includes a high-frequency generator and a balun transformer; further comprising converting an unbalanced radiofrequency signal to a balanced radiofrequency signal in order to generate radiofrequency waves; and applying the radiofrequency waves to the at least one body region.

25. The method of claim 24 wherein the device further comprises a transmatch; and further comprising matching the impedance of the radiofrequency signal.

26. The method of claim 24 further comprising causing no thermal treatment by the magnetic field generating device.

27. The method of claim 23 further comprising activating a muscle pump and reducing visceral white adipose tissue.

28. The method of claim 23 further comprising using a signal from a sensor measuring a physical quantity of a hardware component of the treatment device including one or more of voltage, current, a phase shift, a magnetic flux density or a temperature; and

evaluating the signal and providing at least one maximal treatment parameter including the magnetic flux density, the repetition rate and the impulse duration to an operator in a human perceptible form in order to avoid overheating of the magnetic field generating device, wherein the at least one maximal treatment parameter based on at least another treatment parameter set by the operator.

29. The method of claim 23 further comprising using a signal from a sensor measuring a physical quantity of a hardware component of the treatment device including one or more of voltage, current, a phase shift or a magnetic flux density in order determine an unintended event including a hardware error or a metal object within proximity of the device; and

disabling generating the time-varying magnetic field in the case of determining the unintended event.

30. The method of claim 29 further comprising using at least two magnetic field generating devices, and using the signal from the sensor for generating at least two time-varying magnetic fields by the at least two magnetic field generating devices.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2022
From: BTL HEALTHCARE TECHNOLOGIES A.S.
To: BTL MEDICAL SOLUTIONS A.S.
Reel/Frame 061439/0850 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 5, 2022
From: BTL HEALTHCARE TECHNOLOGIES A.S.
To: BTL MEDICAL SOLUTIONS A.S.
Reel/Frame 063272/0050 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2021
From: BTL MEDICAL TECHNOLOGIES S.R.O.
To: BTL HEALTHCARE TECHNOLOGIES A.S.
Reel/Frame 056526/0492 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2019
From: PROUZA, ONDRA
To: BTL MEDICAL TECHNOLOGIES S.R.O.
Reel/Frame 051054/0046 →
MERGER Recorded Aug 13, 2019
From: MEDICAL TECHNOLOGIES CZ A.S.
To: BTL MEDICAL TECHNOLOGIES S.R.O.
Reel/Frame 050034/0451 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2019
From: BTL HOLDINGS LIMITED
To: MEDICAL TECHNOLOGIES CZ A.S.
Reel/Frame 048166/0023 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2017
From: SCHWARZ, TOMÁ?
To: BTL HOLDINGS LIMITED
Reel/Frame 042575/0432 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 24, 2017
From: MIRDA, JAMES M.; BLACKWELL, JONATHAN E.; HYNES, RICHARD A.
To: WARSAW ORTHOPEDIC
Reel/Frame 042497/0654 →
Continuity (4)
Provisional Application 62357679 · Jul 1, 2016
Provisional Application 62440905 · Dec 30, 2016
Provisional Application 62440922 · Dec 30, 2016
Related Publication 20180001106A1 · Jan 4, 2018